Bank of Montreal Can Has $5.09 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Bank of Montreal Can grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 36,198 shares of the financial services provider’s stock after purchasing an additional 920 shares during the quarter. Bank of Montreal Can’s holdings in iShares Biotechnology ETF were worth $5,086,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Global Assets Advisory LLC bought a new position in iShares Biotechnology ETF in the first quarter valued at approximately $66,059,000. BNP Paribas Financial Markets lifted its stake in shares of iShares Biotechnology ETF by 25.7% in the 1st quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares during the period. Gray Foundation bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $17,890,000. Jane Street Group LLC acquired a new stake in shares of iShares Biotechnology ETF during the first quarter worth $14,386,000. Finally, Cetera Investment Advisers increased its holdings in iShares Biotechnology ETF by 689.4% in the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock valued at $12,498,000 after purchasing an additional 79,541 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $144.77 on Wednesday. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.57. The business’s 50-day moving average price is $145.68 and its two-hundred day moving average price is $138.97.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.